1. Home
  2. BESS vs CTSO Comparison

BESS vs CTSO Comparison

Compare BESS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bimergen Energy Corporation Common Stock

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$1.86

Market Cap

21.6M

Sector

N/A

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

BUY

Current Price

$3.97

Market Cap

23.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BESS
CTSO
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
23.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
BESS
CTSO
Price
$1.86
$3.97
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $9.75
N/A
AVG Volume (30 Days)
★ 50.2K
9.8K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
N/A
★ N/A
Revenue
$168,880.00
★ $22,503,908.00
Revenue This Year
N/A
$4.91
Revenue Next Year
$206.88
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$2.00
$0.30
52 Week High
$6.45
$7.44

Technical Indicators

Market Signals
Indicator
BESS
CTSO
Relative Strength Index (RSI) 26.97 52.20
Support Level N/A $0.47
Resistance Level $3.17 $7.44
Average True Range (ATR) 0.28 0.50
MACD -0.07 -0.32
Stochastic Oscillator 6.85 10.86

Price Performance

Historical Comparison
BESS
CTSO

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: